July 1 (Reuters) - Bayer said on Wednesday it is

consolidating its U.S. glyphosate business into its Ruveon unit,

a day after it asked Washington to impose duties on Chinese

imports of the chemical used in the company's weedkiller

Roundup.

* Bayer, the only U.S. maker of glyphosate, sought duties

against Chinese imports of the chemical and said on Tuesday that

"the domestic glyphosate business as it stands today is not

sustainable", angering farmers who said such a move would raise

herbicide costs.

* The St. Louis-based unit, which remains a Bayer business,

will oversee all aspects of U.S. glyphosate sales, including

pricing, go-to-market strategies, production and logistics, the

company said on Wednesday.

* Bayer said the consolidation of the business was part of

its Crop Science division's five-year restructuring plan.

* "Ruveon is expected to be a more nimble and

well-positioned player within its commodity-based market, which

requires a specialized approach to address competitive

dynamics," Bayer said.

* Last week, the German pharmaceuticals and agriculture

group scored a major legal victory when the U.S. Supreme Court

blocked thousands of state-court lawsuits that accuse Bayer of

failing to warn users that glyphosate causes cancer.

* Ruveon will be led by Bayer veteran Alfonso Alba Ordonez.